Advances in Molecular and Genetic Technologies and the Problems Related to Their Application in Personalized Medicine.

Advances in the global personalized medicine market are directly related to innovations and developments in molecular and genetic technologies. This review focuses on the key trends in the development of these technologies in the healthcare sector. The existing global developments having an impact on the evolution of the personalized medicine market are reviewed.

A Facile Synthesis of Noble-Metal-Free Catalyst Based on Nitrogen Doped Graphene Oxide for Oxygen Reduction Reaction.

A simple method for the mechanochemical synthesis of an effective metal-free electrocatalyst for the oxygen reduction reaction was demonstrated. A nitrogen-doped carbon material was obtained by grinding a mixture of graphene oxide and melamine in a planetary ball mill. The resulting material was characterized by XPS, EPR, and Raman and IR spectroscopy.

Reduced Graphene Oxide Aerogel inside Melamine Sponge as an Electrocatalyst for the Oxygen Reduction Reaction.

A graphene oxide aerogel (GOA) was formed inside a melamine sponge (MS) framework. After reduction with hydrazine at 60 °C, the electrical conductive nitrogen-enriched rGOA-MS composite material with a specific density of 20.1 mg/cm was used to fabricate an electrode, which proved to be a promising electrocatalyst for the oxygen reduction reaction.

Base-rate data and norms for the Rey Auditory Verbal Learning Embedded Performance Validity Indicator.

The present study examines the Rey Auditory Verbal Learning Test (RAVLT) Embedded Performance Validity Indicator (EPVI) for detecting performance validity. This retrospective study analyzes the performance of four groups of 879 participants comprised of 464 clinically referred patients with suspected dementia, 91 forensic patients identified as not exhibiting adequate effort on other measures of response bias, 25 patients with well documented TBI, and a random sample of 198 adults collected in the Gulf State of Oman. The EPVI was also put to the test using normative data collected from the literature.

Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Poor medication adherence is a pervasive problem that causes disability and suffering as well as extensive financial costs among individuals with bipolar disorder (BD). Barriers to adherence are numerous and cross multiple levels, including factors related to bipolar pathology and those unique to an individual's circumstances. External factors, including treatment setting, healthcare system, and broader health policies, can also affect medication adherence in people with BD.